Heart failure in women

Jooyoung (Julia) Shin, Eman Hamad, Sandhya Murthy, Ileana L. Pina

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Heart failure (HF) has steadily increased in prevalence and affects both males and females equally. Despite this, there has been a significant underrepresentation of women in large scale HF trials. This disparity has lead to a deficit in understanding important gender-based differences in pathophysiology, diagnosis and treatment strategies. We review these gaps and explore a biological basis for varying outcomes. Endogenous estrogen plays an important role in epidemiology and outcome. The administration of exogenous estrogen has had varied success in treatment and is outlined extensively below. Additionally, we highlight unique HF syndromes through pregnancy and important sex-specific issues concerning transplant and mechanical circulatory support. A central theme remains: there is a clear need for increased female recruitment in clinical trials, and more studies exploring the role of gender-based biology in HF treatment.

Original languageEnglish (US)
Pages (from-to)172-177
Number of pages6
JournalClinical Cardiology
Volume35
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Heart Failure
Estrogens
Epidemiology
Therapeutics
Clinical Trials
Transplants
Pregnancy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart failure in women. / Shin, Jooyoung (Julia); Hamad, Eman; Murthy, Sandhya; Pina, Ileana L.

In: Clinical Cardiology, Vol. 35, No. 3, 03.2012, p. 172-177.

Research output: Contribution to journalArticle

Shin, JJ, Hamad, E, Murthy, S & Pina, IL 2012, 'Heart failure in women', Clinical Cardiology, vol. 35, no. 3, pp. 172-177. https://doi.org/10.1002/clc.21973
Shin, Jooyoung (Julia) ; Hamad, Eman ; Murthy, Sandhya ; Pina, Ileana L. / Heart failure in women. In: Clinical Cardiology. 2012 ; Vol. 35, No. 3. pp. 172-177.
@article{33fa8b3f34bc4944b77f1656a6b99a20,
title = "Heart failure in women",
abstract = "Heart failure (HF) has steadily increased in prevalence and affects both males and females equally. Despite this, there has been a significant underrepresentation of women in large scale HF trials. This disparity has lead to a deficit in understanding important gender-based differences in pathophysiology, diagnosis and treatment strategies. We review these gaps and explore a biological basis for varying outcomes. Endogenous estrogen plays an important role in epidemiology and outcome. The administration of exogenous estrogen has had varied success in treatment and is outlined extensively below. Additionally, we highlight unique HF syndromes through pregnancy and important sex-specific issues concerning transplant and mechanical circulatory support. A central theme remains: there is a clear need for increased female recruitment in clinical trials, and more studies exploring the role of gender-based biology in HF treatment.",
author = "Shin, {Jooyoung (Julia)} and Eman Hamad and Sandhya Murthy and Pina, {Ileana L.}",
year = "2012",
month = "3",
doi = "10.1002/clc.21973",
language = "English (US)",
volume = "35",
pages = "172--177",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Heart failure in women

AU - Shin, Jooyoung (Julia)

AU - Hamad, Eman

AU - Murthy, Sandhya

AU - Pina, Ileana L.

PY - 2012/3

Y1 - 2012/3

N2 - Heart failure (HF) has steadily increased in prevalence and affects both males and females equally. Despite this, there has been a significant underrepresentation of women in large scale HF trials. This disparity has lead to a deficit in understanding important gender-based differences in pathophysiology, diagnosis and treatment strategies. We review these gaps and explore a biological basis for varying outcomes. Endogenous estrogen plays an important role in epidemiology and outcome. The administration of exogenous estrogen has had varied success in treatment and is outlined extensively below. Additionally, we highlight unique HF syndromes through pregnancy and important sex-specific issues concerning transplant and mechanical circulatory support. A central theme remains: there is a clear need for increased female recruitment in clinical trials, and more studies exploring the role of gender-based biology in HF treatment.

AB - Heart failure (HF) has steadily increased in prevalence and affects both males and females equally. Despite this, there has been a significant underrepresentation of women in large scale HF trials. This disparity has lead to a deficit in understanding important gender-based differences in pathophysiology, diagnosis and treatment strategies. We review these gaps and explore a biological basis for varying outcomes. Endogenous estrogen plays an important role in epidemiology and outcome. The administration of exogenous estrogen has had varied success in treatment and is outlined extensively below. Additionally, we highlight unique HF syndromes through pregnancy and important sex-specific issues concerning transplant and mechanical circulatory support. A central theme remains: there is a clear need for increased female recruitment in clinical trials, and more studies exploring the role of gender-based biology in HF treatment.

UR - http://www.scopus.com/inward/record.url?scp=84858011013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858011013&partnerID=8YFLogxK

U2 - 10.1002/clc.21973

DO - 10.1002/clc.21973

M3 - Article

C2 - 22389122

AN - SCOPUS:84858011013

VL - 35

SP - 172

EP - 177

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 3

ER -